Charles Schwab Investment Management Inc. Boosts Stock Holdings in Encompass Health Co. (NYSE:EHC)

Charles Schwab Investment Management Inc. grew its holdings in Encompass Health Co. (NYSE:EHC) by 0.7% during the 4th quarter, Holdings Channel reports. The fund owned 644,764 shares of the company’s stock after buying an additional 4,345 shares during the period. Charles Schwab Investment Management Inc.’s holdings in Encompass Health were worth $59,544,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. MassMutual Private Wealth & Trust FSB raised its position in Encompass Health by 87.8% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock worth $27,000 after acquiring an additional 137 shares during the period. Avior Wealth Management LLC bought a new position in Encompass Health in the third quarter worth approximately $40,000. Tompkins Financial Corp bought a new position in Encompass Health in the fourth quarter worth approximately $46,000. V Square Quantitative Management LLC raised its position in Encompass Health by 43.8% in the fourth quarter. V Square Quantitative Management LLC now owns 581 shares of the company’s stock worth $54,000 after acquiring an additional 177 shares during the period. Finally, Morse Asset Management Inc bought a new position in Encompass Health in the third quarter worth approximately $68,000. 97.25% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, CAO Andrew L. Price sold 5,042 shares of Encompass Health stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the transaction, the chief accounting officer now directly owns 69,164 shares of the company’s stock, valued at approximately $6,798,129.56. The trade was a 6.79 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 2.10% of the company’s stock.

Encompass Health Stock Performance

Shares of NYSE:EHC opened at $94.18 on Thursday. Encompass Health Co. has a 52 week low of $74.27 and a 52 week high of $104.55. The stock has a market capitalization of $9.48 billion, a P/E ratio of 21.12, a PEG ratio of 2.31 and a beta of 0.92. The firm has a fifty day simple moving average of $97.22 and a two-hundred day simple moving average of $96.88. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Thursday, February 6th. The company reported $1.17 EPS for the quarter, topping analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. On average, analysts expect that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be paid a $0.17 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.72%. Encompass Health’s payout ratio is currently 15.25%.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the stock. Royal Bank of Canada reiterated an “outperform” rating and issued a $110.00 price target on shares of Encompass Health in a research report on Tuesday, February 11th. StockNews.com upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a research report on Saturday, February 15th. William Blair restated an “outperform” rating on shares of Encompass Health in a research report on Friday, February 7th. Barclays raised their price objective on shares of Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a research report on Friday, February 7th. Finally, KeyCorp raised their price objective on shares of Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a research report on Monday, February 10th. Ten equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $107.67.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.